MAGNAPERA, ALESSIA
MAGNAPERA, ALESSIA
Dipartimento di Medicina Sperimentale
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity.
2025-01-01 Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity.
2024-01-01 Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R
An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity
2025-01-01 Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity.
2025-01-01 D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity.
2024-01-01 Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R
HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential.
2025-01-01 D'Anna, S; Piermatteo, L; Di Lorenzo, A; Carioti, L; Brancaccio, G; Teti, E; Grossi, I; Castelli, C; Magnapera, A; Malagnino, V; Iannetta, M; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity.
2025-01-01 Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity.
2025-01-01 Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Salpini, R; Svicher, V
Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles
2025-05-30 Magnapera, A; Riccio, A; Curcio, A; Tramontozzi, C; Piermatteo, L; D'Anna, S; Alcaro, S; Alteri, C; La Frazia, S; Artese, A; Salpini, R; Svicher, V
Kinetics of occult hepatitis B infection in people with HIV switching from HBV-active ART to long-acting cabotegravir/rilpivirine
2025-01-01 D’Anna, S; Magnapera, A; Grossi, I; Capra, N; Lolatto, R; Piermatteo, L; Bagaglio, S; Muccini, C; Salpini, R; Castagna, A; Svicher, V; Morsica, G
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2025 | A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. | Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. | Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R | Intervento a convegno | |
| 1-gen-2025 | An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity | Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. | D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. | Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2025 | HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential. | D'Anna, S; Piermatteo, L; Di Lorenzo, A; Carioti, L; Brancaccio, G; Teti, E; Grossi, I; Castelli, C; Magnapera, A; Malagnino, V; Iannetta, M; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2025 | HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. | Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | HDV sub-genotype 1 is characterized by increased genetic variability, which can promote the emergence of divergent genetic pathways that modulate HDV replicative potential and cytolytic activity. | Magnapera, A; Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Gaeta, Gb; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Salpini, R; Svicher, V | Intervento a convegno | |
| 30-mag-2025 | Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance Profiles | Magnapera, A; Riccio, A; Curcio, A; Tramontozzi, C; Piermatteo, L; D'Anna, S; Alcaro, S; Alteri, C; La Frazia, S; Artese, A; Salpini, R; Svicher, V | Articolo su rivista | |
| 1-gen-2025 | Kinetics of occult hepatitis B infection in people with HIV switching from HBV-active ART to long-acting cabotegravir/rilpivirine | D’Anna, S; Magnapera, A; Grossi, I; Capra, N; Lolatto, R; Piermatteo, L; Bagaglio, S; Muccini, C; Salpini, R; Castagna, A; Svicher, V; Morsica, G | Intervento a convegno |